- Therapeutic Cataract & Refractive
- Lens Technology
- Glasses
- Ptosis
- AMD
- COVID-19
- DME
- Ocular Surface Disease
- Optic Relief
- Geographic Atrophy
- Cornea
- Conjunctivitis
- LASIK
- Myopia
- Presbyopia
- Allergy
- Nutrition
- Pediatrics
- Retina
- Cataract
- Contact Lenses
- Lid and Lash
- Dry Eye
- Glaucoma
- Refractive Surgery
- Comanagement
- Blepharitis
- OCT
- Patient Care
- Diabetic Eye Disease
- Technology
B+L receives FDA clearance for Biotrue ONEday for Presbyopia, launches Soothe XP eye drops
Baush + Lomb announced that the U.S. Food and Drug Administration (FDA) has issued marketing clearance for Biotrue ONEday for Presbyopia (nesofilcon A) soft (hydrophilic) daily disposable multifocal contact lenses at the American Optometric Association’s Optometry’s Meeting.
Philadelphia-Bausch + Lomb announced that the U.S. Food and Drug Administration (FDA) has issued marketing clearance for Biotrue ONEday for Presbyopia (nesofilcon A) soft (hydrophilic) daily disposable multifocal contact lenses at the American Optometric Association’s Optometry’s Meeting.
The lenses feature Baush + Lomb’s 3-Zone Progressive design and HyperGel material, which will provide comfortable vision at near, intermediate, and distance throughout the day, according to the company. According to Bausch + Lomb, the HyperGel material meets the oxygen level the eye needs, matches the cornea’s water content, and mimics the lipid layer by using a surfactant-enriched lens surface to retain moisture and shape.
“For people with presbyopia, finding a comfortable daily disposable contact lens that provides clear vision at all distances can be a challenge. The new Biotrue ONEday for Presbyopia combines the bio-inspired design and benefits that contact lens wearers have come to expect from Biotrue ONEday, with the outstanding optical 3-Zone Progressive design of PureVision2 Multi-Focal for Presbyopia,” said Mark McKenna, vice president and general manager, Vision Care, Bausch + Lomb. “We’re confident that the comfort and clarity that this new lens offers will also be a welcome solution for eye care professionals.”
In related news, the company also announced the return to the market of Soothe Xtra Protection (XP) eye drops with Restoryl, an emulsion system featuring a proprietary blend of mineral oils and interfacial molecules. According to Bausch + Lomb, the eye drops target the main source of dry eye symptoms by replenishing the lipid layer of the tear film.
“By restoring lipid layer thickness, Soothe XP with Restoryl addresses a key component in the onset of dry eye symptoms. We are pleased to bring back the product to eye care professionals and consumers,” said Cal Roberts, MD, chief medical officer, Bausch + Lomb.
Sooth XP is available at Walmart now, but will be available at Target in July. Further availability is expected over the coming months.
